About Bernardo Goulart
Dr. Bernardo Goulart has built a distinguished career in medical oncology, primarily serving at the Seattle Cancer Care Alliance. He has recently transitioned to the role of a medical officer at the U.S. Food and Drug Administration. In his current position, he conducts detailed clinical assessments of new oncology drug submissions. Raised by a physician, Dr. Goulart has cultivated deep empathy for his patients, particularly those suffering from mesothelioma, a condition often contracted through industrial exposure to asbestos.
Dr. Goulart is deeply moved by the plight of these predominantly blue-collar patients, whose condition arose while providing for their families. "Their condition is a result of their dedication to supporting their loved ones, and it is imperative they receive the highest standard of care. My goal is to contribute positively to their treatment," he emphasizes.
Dr. Goulart's academic journey led him to prestigious medical fellowships at Massachusetts General Hospital and the University of Washington Medical Center following his graduation from the Federal University of Rio de Janeiro. He is board-certified in Internal Medicine. His research endeavors have been focused on the pharmacoeconomics of cancer treatments, and his clinical specialization lies in thoracic oncology as well as head and neck cancers.
A fervent advocate for precision medicine, Dr. Goulart champions the development and use of molecularly targeted therapies to tailor more effective treatment plans. His tenure at the Seattle Cancer Care Alliance was marked by a commitment to advancing treatment for mesothelioma. "Raising awareness about our specialized care facilities is crucial. Many medical professionals unfamiliar with mesothelioma may feel powerless against it, citing historical treatment challenges. However, significant advances are being made, and we are at the forefront of these developments," Dr. Goulart asserts.
Dr. Goulart's combination of personal compassion and professional expertise makes him a pivotal figure in oncology. He strives to enhance patient outcomes through innovation and dedicated care.
Currently, he practices at the Seattle Cancer Care Alliance located at 825 Eastlake Ave E, Seattle, WA 98109, and can be reached at (206) 667-2778.